Serum Procalcitonin in Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. One of the most important events in the course of COPD is acute exacerbation. Acute exacerbation of COPD (AECOPD) is characterized by the aggravation of dyspnea, cough, and sputum. Chronic obstructive pulmona...
Main Authors: | Farzaneh Akbari, Mina Delghandi, Fariba Rezaeetalab |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2021-03-01
|
Series: | Reviews in Clinical Medicine |
Subjects: | |
Online Access: | https://rcm.mums.ac.ir/article_18044_19e3e98c0c7f4c80ac18d893b878dc2b.pdf |
Similar Items
-
Investigation serum procalcitonin in patients with exacerbation of obstructive pulmonary disease
by: Mina Delghandi, et al.
Published: (2020-12-01) -
The value of serum procalcitonin among exacerbated COPD patients
by: Ashraf Abd El Halim, et al.
Published: (2015-10-01) -
Effect of procalcitonin-guided therapy on antibiotic usage in the management of patients with chronic obstructive pulmonary disease with acute exacerbation
by: Randa S. Mohammad, et al.
Published: (2016-06-01) -
Procalcitonin for Antibiotic Prescription in Chronic Obstructive Pulmonary Disease Exacerbations: Systematic Review, Meta-Analysis, and Clinical Perspective
by: Ken Chen, et al.
Published: (2020-07-01) -
Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD
by: Corti C, et al.
Published: (2016-06-01)